Medium materiality6/10
Rigel Pharmaceuticals price target raised to $85 from $57 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target raised; current price $41.74; upside potential to $85; priceChangeSinceSignal +2.02
- Target raised to 85; current price 41.74; upside potential.
Key facts
- 01
Target: $85
- 02
Posted price: $41.74
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Joseph Pantginis
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.